However, RALY selectively regulates the alternative splicing of transcription factors mainly associated with immune/inflammatory response and tumorigenesis in HeLa cells, which affect the cellular process, including proliferation and apoptosis, and metabolism in cancer cells. This evidence concerns the gene RALY and cancer.